[en] Chryseobacterium and other genera belonging to the family Flavobacteriaceae include organisms that can behave as human pathogens and are known to cause different kinds of infections. Several Flavobacteriaceae, including Chryseobacterium indologenes, are naturally resistant to beta-lactam antibiotics (including carbapenems), due to the production of a resident metallo-beta-lactamase. Although C. indologenes presently constitutes a limited clinical threat, the incidence of infections caused by this organism is increasing in some settings, where isolates that exhibit multidrug resistance phenotypes (that include aminoglycosides and quinolones) have been described. Here we report the identification and characterization of a new IND-type variant from a C. indologenes isolate from Burkina Faso resistant to beta-lactams and aminoglycosides. Its sequence identity with other IND-type metallo-beta-lactamases ranges from 72 to 90% (with IND-4 and IND-5, respectively). The purified enzyme exhibited N-terminal heterogeneity and a post-translational modification, consisting in the presence of a pyroglutamate residue at the N-terminus. IND-6 shows a broad substrate profile, with overall higher turnover rates than IND-5 and higher activities than IND-2 and IND-5 against ceftazidime and cefepime.